Navigation Links
Bavarian Nordic Publishes its Annual Results 2008
Date:3/27/2009

nt and obliged to notify the Company of transactions involving Bavarian Nordic securities is awarded 5,000 warrants under the abovementioned award of warrants.

The value of each warrant equals DKK 39 and is calculated on the Black-Scholes model with a risk-free interest rate of 2.5 per cent and on the historical volatility of the shares. The calculation is based on a market value of the share of DKK 103 per share.

The award of warrants will incur consequential amendments to the Articles of Association.

Forward-looking statements

This announcement includes "forward-looking statements" that involve risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.

About Bavarian Nordic

Bavarian Nordic A/S is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-generation smallpox vaccine, IMVAMUNE(R).

Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA.

For more informati
'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
2. Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
3. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
4. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
5. Bavarian Nordics Case Against Oxford BioMedica
6. Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting
7. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
8. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
9. Consortium publishes Phase II map of human genetic variation
10. The Lancet Publishes Vasogens ACCLAIM Results
11. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...s available in German . , Whether it,s CD p... tags (Radio Frequency Identification) are increas...ake it possible to label objects or goods and iden...propriate scanner can read and process the data co...to goods under production conditions of up to 100 ...
(Date:11/24/2009)... The New York investment bank KTA Capital,...agreed an AU$6.7 mil convertible note private plac...ate placement was arranged by KTA Capital as Neure... New York (PRWEB) November 23, ...TA Capital, LLC ("KTA Capital") has anno...
(Date:11/24/2009)...,Iceland,November24/PRNewswire-FirstCall/--deCODE,...sreceivednoticefrom,theNasdaqStockMarketthattradin...mber30,2009andaForm25-NSEwillbefiledwiththe,Securi...ommonstock,fromlistingonNasdaq,unlessthecompanyfil...hecompanyhasfiledsuchanappeal,which,willstaythesus...
(Date:11/24/2009)...,Iceland,November24/PRNewswire-FirstCall/--deCODE,...valofallofits,"firstday"motionsbytheU.S.Bankruptcy...").deCODElastweekfiledavoluntarypetitionfor,relief...he,BankruptcyCourt. , TheordersissuedbytheBan...businessduringtheChapter11proceedings.Inparticular...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...S CLINICALS AND DRUG DEVELOPMENT, ROCKVILLE, Md.,...: CUR ) announced that Dr. Thomas Hazel will be,r...Research. He will be,working with Dr. Karl Johe, N... manage the company,s upcoming clinical trial for ... disease), and complete,development of Neuralstem,...
... Advance Clinical Development Of Lead Drug Candida...ma today announced the,closing of a CDN $45 millio...ew investor, Mitsubishi Tanabe Pharma Corporation ...vestors including Vengrowth Advanced Life,Sciences..., Novo A/S,Canadian Medical Discoveries Fund Inc.,...
...ck Exchange Symbol: MS, EDMONTON, July 30 /PRNews...leading developer in the treatment of multiple scl... President and CEO, will present at the BMO,Capita...York., WHEN: Wednesday August 6th at 8:30am (Ea..., New York About BioMS Medical Corp., BioMS Medi...
Other Biology Technology:Neuralstem Fills Key Product Development Position 2Cytochroma Closes $45 Million Series C Financing 2Cytochroma Closes $45 Million Series C Financing 3BioMS Medical to present at BMO Healthcare Conference 2
(Date:11/24/2009)...kable class of ring-shaped protein motors has been...ey National Laboratory (Berkeley Lab) using a stat...he Advanced Light Source (ALS). These protein moto...cation, and are vital to the survival of all biolo... the human papillomavirus, which has been linked t...
(Date:11/24/2009)... held secrets of the earth,s history locked in its...ry little information on the environments that hav... years. Now, a team of researchers from nine insti...ne of $10 million dollars by the National Science ... literally. These scientists will drill through t...
(Date:11/24/2009)...nish . , The presence of increased body fat,...ances in the blood, hinders the loss and maintenan...of the University of Navarra conducted by Estbaliz...rmacy. , The project, entitled "A nutrigenetic a...f body weight and inflammation," examines how the ...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2It can be predicted the reaction obese patients will have to a diet 2Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 1Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 2Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 3Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 4Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 5Famous Names Get Single Neurons Fired Up 52757 1Famous Names Get Single Neurons Fired Up 52757 2PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 1PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 2PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 3PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 4
... Magnetic Snakes Create Water Current , M. Belkin...al Review Letters (forthcoming) , Physicists at A...c particles suspended in water and subjected to an... structures that can control the flow of the surro... snake are a few centimeters long, but the team en...
...A dinosaur skeleton found 24 years ago in Montana ... links North American,dinosaurs with Asian dinosau...s, walked on two feet and stood about three feet t... million years old , A paper on the finding was p...rtebrate Paleontology, co-author Jack Horner said ...
...ger Expected to Strengthen Position in Enterprise ...ology Portfolio with Established and Growing ...D, Wash., and AUSTIN, Texas, Sept. 4 ,Saflink Corp...ider of,solutions designed to verify identity, sec...I, Inc., a privately held provider of enterprise,s...
Other Biology News:Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery 2Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery 3New dinosaur species found in Montana 2Saflink and IdentiPHI Announce Merger Agreement 2Saflink and IdentiPHI Announce Merger Agreement 3Saflink and IdentiPHI Announce Merger Agreement 4Saflink and IdentiPHI Announce Merger Agreement 5
... is a powerful tool for evaluating DNA-protein int...etardation, the assay is based on the principle th...l migrate differently than a DNA-protein complex. ... a nonradioactive system for performing EMSA using...
...ter volume and fluorescence provides unsurpassed p...l counting. This flow cytometer has multiple excit... fluorochrome selection for a variety of multi-col...ger, more expensive systems. This multiparameter s...
... for the uniform amplification and subsequent dire...om small samples. This method has been designed to...tion and labeling procedure for arrayCGH analysis....e (QIAGEN) and a ULS Labeling Kit module containin...
...uperior to transfection in some applications. For...LSin you can study lethal proteins and control the...ise, delivery of blocking antibodies may provide m...experiments. ,With PULSin you can target intrac...
Biology Products: